ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tuberculin Pure Protein Derivative Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-30A16777
Home | Market Reports | Health| Health Conditions
Global Tuberculin Pure Protein Derivative Market Research Report 2024
BUY CHAPTERS

Global Tuberculin Pure Protein Derivative Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-30A16777
Report
November 2025
Pages:141
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Pasteur
Zoetis Inc
Par Sterile
Statens Serum Institut
Japan BCG Laboratory
Thermo Fisher (Prionics)
Sanroad Biological
CNBG

Tuberculin Pure Protein Derivative Market

The global Tuberculin Pure Protein Derivative market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Pure protein derivatives of tuberculin are used for clinical diagnosis of tuberculosis, selection of subjects for BCG vaccination and monitoring of the body's immune response after BCG vaccination.
From a downstream perspective, Tuberculosis Diagnostic Reagents accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Tuberculin Pure Protein Derivative leading manufacturers including Sanofi Pasteur, Zoetis, Par Sterile, Statens Serum Institut, Japan BCG Laboratory, Thermo Fisher (Prionics), Sanroad Biological, CNBG, etc., dominate supply; the top five capture approximately % of global revenue, with Sanofi Pasteur leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Tuberculin Pure Protein Derivative market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Tuberculin Pure Protein Derivative Market Report

Report Metric Details
Report Name Tuberculin Pure Protein Derivative Market
Segment by Type
  • PPD-S
  • PPD RT23
  • Others
Segment by Application
  • Tuberculosis Diagnostic Reagents
  • Tuberculosis Vaccine
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi Pasteur, Zoetis, Par Sterile, Statens Serum Institut, Japan BCG Laboratory, Thermo Fisher (Prionics), Sanroad Biological, CNBG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Tuberculin Pure Protein Derivative study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Tuberculin Pure Protein Derivative Market report?

Ans: The main players in the Tuberculin Pure Protein Derivative Market are Sanofi Pasteur, Zoetis, Par Sterile, Statens Serum Institut, Japan BCG Laboratory, Thermo Fisher (Prionics), Sanroad Biological, CNBG

What are the Application segmentation covered in the Tuberculin Pure Protein Derivative Market report?

Ans: The Applications covered in the Tuberculin Pure Protein Derivative Market report are Tuberculosis Diagnostic Reagents, Tuberculosis Vaccine, Other

What are the Type segmentation covered in the Tuberculin Pure Protein Derivative Market report?

Ans: The Types covered in the Tuberculin Pure Protein Derivative Market report are PPD-S, PPD RT23, Others

1 Study Coverage
1.1 Introduction to Tuberculin Pure Protein Derivative: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Tuberculin Pure Protein Derivative Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 PPD-S
1.2.3 PPD RT23
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Tuberculin Pure Protein Derivative Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Tuberculosis Diagnostic Reagents
1.3.3 Tuberculosis Vaccine
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tuberculin Pure Protein Derivative Revenue Estimates and Forecasts 2020-2031
2.2 Global Tuberculin Pure Protein Derivative Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Tuberculin Pure Protein Derivative Sales Estimates and Forecasts 2020-2031
2.4 Global Tuberculin Pure Protein Derivative Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Tuberculin Pure Protein Derivative Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Tuberculin Pure Protein Derivative Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 PPD-S Market Size by Manufacturers
3.5.2 PPD RT23 Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Tuberculin Pure Protein Derivative Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Tuberculin Pure Protein Derivative Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Tuberculin Pure Protein Derivative Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Tuberculin Pure Protein Derivative Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Tuberculin Pure Protein Derivative Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Tuberculin Pure Protein Derivative Sales and Revenue by Type (2020-2031)
6.4 North America Tuberculin Pure Protein Derivative Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Tuberculin Pure Protein Derivative Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Tuberculin Pure Protein Derivative Sales and Revenue by Type (2020-2031)
7.4 Europe Tuberculin Pure Protein Derivative Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Tuberculin Pure Protein Derivative Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Tuberculin Pure Protein Derivative Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Tuberculin Pure Protein Derivative Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Tuberculin Pure Protein Derivative Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Tuberculin Pure Protein Derivative Sales and Revenue by Type (2020-2031)
9.4 Central and South America Tuberculin Pure Protein Derivative Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Tuberculin Pure Protein Derivative Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Tuberculin Pure Protein Derivative Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Tuberculin Pure Protein Derivative Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Tuberculin Pure Protein Derivative Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Business Overview
11.1.3 Sanofi Pasteur Tuberculin Pure Protein Derivative Product Models, Descriptions and Specifications
11.1.4 Sanofi Pasteur Tuberculin Pure Protein Derivative Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Sanofi Pasteur Tuberculin Pure Protein Derivative Sales by Product in 2024
11.1.6 Sanofi Pasteur Tuberculin Pure Protein Derivative Sales by Application in 2024
11.1.7 Sanofi Pasteur Tuberculin Pure Protein Derivative Sales by Geographic Area in 2024
11.1.8 Sanofi Pasteur Tuberculin Pure Protein Derivative SWOT Analysis
11.1.9 Sanofi Pasteur Recent Developments
11.2 Zoetis
11.2.1 Zoetis Corporation Information
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Tuberculin Pure Protein Derivative Product Models, Descriptions and Specifications
11.2.4 Zoetis Tuberculin Pure Protein Derivative Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Zoetis Tuberculin Pure Protein Derivative Sales by Product in 2024
11.2.6 Zoetis Tuberculin Pure Protein Derivative Sales by Application in 2024
11.2.7 Zoetis Tuberculin Pure Protein Derivative Sales by Geographic Area in 2024
11.2.8 Zoetis Tuberculin Pure Protein Derivative SWOT Analysis
11.2.9 Zoetis Recent Developments
11.3 Par Sterile
11.3.1 Par Sterile Corporation Information
11.3.2 Par Sterile Business Overview
11.3.3 Par Sterile Tuberculin Pure Protein Derivative Product Models, Descriptions and Specifications
11.3.4 Par Sterile Tuberculin Pure Protein Derivative Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Par Sterile Tuberculin Pure Protein Derivative Sales by Product in 2024
11.3.6 Par Sterile Tuberculin Pure Protein Derivative Sales by Application in 2024
11.3.7 Par Sterile Tuberculin Pure Protein Derivative Sales by Geographic Area in 2024
11.3.8 Par Sterile Tuberculin Pure Protein Derivative SWOT Analysis
11.3.9 Par Sterile Recent Developments
11.4 Statens Serum Institut
11.4.1 Statens Serum Institut Corporation Information
11.4.2 Statens Serum Institut Business Overview
11.4.3 Statens Serum Institut Tuberculin Pure Protein Derivative Product Models, Descriptions and Specifications
11.4.4 Statens Serum Institut Tuberculin Pure Protein Derivative Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Statens Serum Institut Tuberculin Pure Protein Derivative Sales by Product in 2024
11.4.6 Statens Serum Institut Tuberculin Pure Protein Derivative Sales by Application in 2024
11.4.7 Statens Serum Institut Tuberculin Pure Protein Derivative Sales by Geographic Area in 2024
11.4.8 Statens Serum Institut Tuberculin Pure Protein Derivative SWOT Analysis
11.4.9 Statens Serum Institut Recent Developments
11.5 Japan BCG Laboratory
11.5.1 Japan BCG Laboratory Corporation Information
11.5.2 Japan BCG Laboratory Business Overview
11.5.3 Japan BCG Laboratory Tuberculin Pure Protein Derivative Product Models, Descriptions and Specifications
11.5.4 Japan BCG Laboratory Tuberculin Pure Protein Derivative Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Japan BCG Laboratory Tuberculin Pure Protein Derivative Sales by Product in 2024
11.5.6 Japan BCG Laboratory Tuberculin Pure Protein Derivative Sales by Application in 2024
11.5.7 Japan BCG Laboratory Tuberculin Pure Protein Derivative Sales by Geographic Area in 2024
11.5.8 Japan BCG Laboratory Tuberculin Pure Protein Derivative SWOT Analysis
11.5.9 Japan BCG Laboratory Recent Developments
11.6 Thermo Fisher (Prionics)
11.6.1 Thermo Fisher (Prionics) Corporation Information
11.6.2 Thermo Fisher (Prionics) Business Overview
11.6.3 Thermo Fisher (Prionics) Tuberculin Pure Protein Derivative Product Models, Descriptions and Specifications
11.6.4 Thermo Fisher (Prionics) Tuberculin Pure Protein Derivative Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Thermo Fisher (Prionics) Recent Developments
11.7 Sanroad Biological
11.7.1 Sanroad Biological Corporation Information
11.7.2 Sanroad Biological Business Overview
11.7.3 Sanroad Biological Tuberculin Pure Protein Derivative Product Models, Descriptions and Specifications
11.7.4 Sanroad Biological Tuberculin Pure Protein Derivative Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Sanroad Biological Recent Developments
11.8 CNBG
11.8.1 CNBG Corporation Information
11.8.2 CNBG Business Overview
11.8.3 CNBG Tuberculin Pure Protein Derivative Product Models, Descriptions and Specifications
11.8.4 CNBG Tuberculin Pure Protein Derivative Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 CNBG Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Tuberculin Pure Protein Derivative Industry Chain
12.2 Tuberculin Pure Protein Derivative Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Tuberculin Pure Protein Derivative Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Tuberculin Pure Protein Derivative Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Tuberculin Pure Protein Derivative Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Tuberculin Pure Protein Derivative Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Sanofi Pasteur
Zoetis Inc
Par Sterile
Statens Serum Institut
Japan BCG Laboratory
Thermo Fisher (Prionics)
Sanroad Biological
CNBG
List of Tables
 Table 1. Global Tuberculin Pure Protein Derivative Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Tuberculin Pure Protein Derivative Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Tuberculin Pure Protein Derivative Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Tuberculin Pure Protein Derivative Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Tuberculin Pure Protein Derivative Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Tuberculin Pure Protein Derivative Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Tuberculin Pure Protein Derivative Sales by Region (2020-2025) & (Units)
 Table 8. Global Tuberculin Pure Protein Derivative Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Tuberculin Pure Protein Derivative Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Tuberculin Pure Protein Derivative Sales Share by Manufacturers (2020-2025)
 Table 12. Global Tuberculin Pure Protein Derivative Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Tuberculin Pure Protein Derivative Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Tuberculin Pure Protein Derivative by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculin Pure Protein Derivative as of 2024)
 Table 16. Global Tuberculin Pure Protein Derivative Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Tuberculin Pure Protein Derivative Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Tuberculin Pure Protein Derivative Manufacturing Base and Headquarters
 Table 19. Global Tuberculin Pure Protein Derivative Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Tuberculin Pure Protein Derivative Sales by Type (2020-2025) & (Units)
 Table 23. Global Tuberculin Pure Protein Derivative Sales by Type (2026-2031) & (Units)
 Table 24. Global Tuberculin Pure Protein Derivative Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Tuberculin Pure Protein Derivative Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Tuberculin Pure Protein Derivative ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Tuberculin Pure Protein Derivative Sales by Application (2020-2025) & (Units)
 Table 29. Global Tuberculin Pure Protein Derivative Sales by Application (2026-2031) & (Units)
 Table 30. Tuberculin Pure Protein Derivative High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Tuberculin Pure Protein Derivative Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Tuberculin Pure Protein Derivative Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Tuberculin Pure Protein Derivative ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Tuberculin Pure Protein Derivative Growth Accelerators and Market Barriers
 Table 37. North America Tuberculin Pure Protein Derivative Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Tuberculin Pure Protein Derivative Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Tuberculin Pure Protein Derivative Growth Accelerators and Market Barriers
 Table 40. Europe Tuberculin Pure Protein Derivative Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Tuberculin Pure Protein Derivative Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Tuberculin Pure Protein Derivative Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Tuberculin Pure Protein Derivative Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Tuberculin Pure Protein Derivative Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Tuberculin Pure Protein Derivative Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Tuberculin Pure Protein Derivative Investment Opportunities and Key Challenges
 Table 47. Central and South America Tuberculin Pure Protein Derivative Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Tuberculin Pure Protein Derivative Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Tuberculin Pure Protein Derivative Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Sanofi Pasteur Corporation Information
 Table 51. Sanofi Pasteur Description and Major Businesses
 Table 52. Sanofi Pasteur Product Models, Descriptions and Specifications
 Table 53. Sanofi Pasteur Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Sanofi Pasteur Sales Value Proportion by Product in 2024
 Table 55. Sanofi Pasteur Sales Value Proportion by Application in 2024
 Table 56. Sanofi Pasteur Sales Value Proportion by Geographic Area in 2024
 Table 57. Sanofi Pasteur Tuberculin Pure Protein Derivative SWOT Analysis
 Table 58. Sanofi Pasteur Recent Developments
 Table 59. Zoetis Corporation Information
 Table 60. Zoetis Description and Major Businesses
 Table 61. Zoetis Product Models, Descriptions and Specifications
 Table 62. Zoetis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Zoetis Sales Value Proportion by Product in 2024
 Table 64. Zoetis Sales Value Proportion by Application in 2024
 Table 65. Zoetis Sales Value Proportion by Geographic Area in 2024
 Table 66. Zoetis Tuberculin Pure Protein Derivative SWOT Analysis
 Table 67. Zoetis Recent Developments
 Table 68. Par Sterile Corporation Information
 Table 69. Par Sterile Description and Major Businesses
 Table 70. Par Sterile Product Models, Descriptions and Specifications
 Table 71. Par Sterile Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Par Sterile Sales Value Proportion by Product in 2024
 Table 73. Par Sterile Sales Value Proportion by Application in 2024
 Table 74. Par Sterile Sales Value Proportion by Geographic Area in 2024
 Table 75. Par Sterile Tuberculin Pure Protein Derivative SWOT Analysis
 Table 76. Par Sterile Recent Developments
 Table 77. Statens Serum Institut Corporation Information
 Table 78. Statens Serum Institut Description and Major Businesses
 Table 79. Statens Serum Institut Product Models, Descriptions and Specifications
 Table 80. Statens Serum Institut Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Statens Serum Institut Sales Value Proportion by Product in 2024
 Table 82. Statens Serum Institut Sales Value Proportion by Application in 2024
 Table 83. Statens Serum Institut Sales Value Proportion by Geographic Area in 2024
 Table 84. Statens Serum Institut Tuberculin Pure Protein Derivative SWOT Analysis
 Table 85. Statens Serum Institut Recent Developments
 Table 86. Japan BCG Laboratory Corporation Information
 Table 87. Japan BCG Laboratory Description and Major Businesses
 Table 88. Japan BCG Laboratory Product Models, Descriptions and Specifications
 Table 89. Japan BCG Laboratory Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Japan BCG Laboratory Sales Value Proportion by Product in 2024
 Table 91. Japan BCG Laboratory Sales Value Proportion by Application in 2024
 Table 92. Japan BCG Laboratory Sales Value Proportion by Geographic Area in 2024
 Table 93. Japan BCG Laboratory Tuberculin Pure Protein Derivative SWOT Analysis
 Table 94. Japan BCG Laboratory Recent Developments
 Table 95. Thermo Fisher (Prionics) Corporation Information
 Table 96. Thermo Fisher (Prionics) Description and Major Businesses
 Table 97. Thermo Fisher (Prionics) Product Models, Descriptions and Specifications
 Table 98. Thermo Fisher (Prionics) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Thermo Fisher (Prionics) Recent Developments
 Table 100. Sanroad Biological Corporation Information
 Table 101. Sanroad Biological Description and Major Businesses
 Table 102. Sanroad Biological Product Models, Descriptions and Specifications
 Table 103. Sanroad Biological Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Sanroad Biological Recent Developments
 Table 105. CNBG Corporation Information
 Table 106. CNBG Description and Major Businesses
 Table 107. CNBG Product Models, Descriptions and Specifications
 Table 108. CNBG Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. CNBG Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Tuberculin Pure Protein Derivative Product Picture
 Figure 2. Global Tuberculin Pure Protein Derivative Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. PPD-S Product Picture
 Figure 4. PPD RT23 Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Tuberculin Pure Protein Derivative Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Tuberculosis Diagnostic Reagents
 Figure 8. Tuberculosis Vaccine
 Figure 9. Other
 Figure 10. Tuberculin Pure Protein Derivative Report Years Considered
 Figure 11. Global Tuberculin Pure Protein Derivative Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Tuberculin Pure Protein Derivative Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Tuberculin Pure Protein Derivative Revenue Market Share by Region (2020-2031)
 Figure 15. Global Tuberculin Pure Protein Derivative Sales (2020-2031) & (Units)
 Figure 16. Global Tuberculin Pure Protein Derivative Sales (CAGR) by Region (2020-2031) (Units)
 Figure 17. Global Tuberculin Pure Protein Derivative Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Tuberculin Pure Protein Derivative Sales Volume Market Share in 2024
 Figure 19. Global Tuberculin Pure Protein Derivative Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. PPD-S Revenue Market Share by Manufacturer in 2024
 Figure 22. PPD RT23 Revenue Market Share by Manufacturer in 2024
 Figure 23. Others Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Tuberculin Pure Protein Derivative Sales Market Share by Type (2020-2031)
 Figure 25. Global Tuberculin Pure Protein Derivative Revenue Market Share by Type (2020-2031)
 Figure 26. Global Tuberculin Pure Protein Derivative Sales Market Share by Application (2020-2031)
 Figure 27. Global Tuberculin Pure Protein Derivative Revenue Market Share by Application (2020-2031)
 Figure 28. North America Tuberculin Pure Protein Derivative Sales YoY (2020-2031) & (Units)
 Figure 29. North America Tuberculin Pure Protein Derivative Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) in 2024
 Figure 31. North America Tuberculin Pure Protein Derivative Sales Volume (Units) by Type (2020- 2031)
 Figure 32. North America Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Tuberculin Pure Protein Derivative Sales Volume (Units) by Application (2020-2031)
 Figure 34. North America Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Tuberculin Pure Protein Derivative Sales YoY (2020-2031) & (Units)
 Figure 39. Europe Tuberculin Pure Protein Derivative Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Tuberculin Pure Protein Derivative Sales Volume (Units) by Type (2020-2031)
 Figure 42. Europe Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Tuberculin Pure Protein Derivative Sales Volume (Units) by Application (2020-2031)
 Figure 44. Europe Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 46. France Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Tuberculin Pure Protein Derivative Sales YoY (2020-2031) & (Units)
 Figure 51. Asia-Pacific Tuberculin Pure Protein Derivative Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Tuberculin Pure Protein Derivative Sales Volume (Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Tuberculin Pure Protein Derivative Sales Volume (Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 61. India Tuberculin Pure Protein Derivative Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Tuberculin Pure Protein Derivative Sales YoY (2020-2031) & (Units)
 Figure 63. Central and South America Tuberculin Pure Protein Derivative Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Tuberculin Pure Protein Derivative Sales Volume (Units) by Type (2021-2031)
 Figure 66. Central and South America Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Tuberculin Pure Protein Derivative Sales Volume (Units) by Application (2020-2031)
 Figure 68. Central and South America Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Tuberculin Pure Protein Derivative Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Tuberculin Pure Protein Derivative Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Tuberculin Pure Protein Derivative Sales YoY (2020-2031) & (Units)
 Figure 72. Middle East and Africa Tuberculin Pure Protein Derivative Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Tuberculin Pure Protein Derivative Sales Volume (Units) by Type (2021-2031)
 Figure 75. South America Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Tuberculin Pure Protein Derivative Sales Volume (Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Tuberculin Pure Protein Derivative Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Tuberculin Pure Protein Derivative Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Tuberculin Pure Protein Derivative Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Tuberculin Pure Protein Derivative Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Tuberculin Pure Protein Derivative Revenue (2020-2025) & (US$ Million)
 Figure 82. Tuberculin Pure Protein Derivative Industry Chain Mapping
 Figure 83. Regional Tuberculin Pure Protein Derivative Manufacturing Base Distribution (%)
 Figure 84. Global Tuberculin Pure Protein Derivative Production Market Share by Region (2020-2031)
 Figure 85. Tuberculin Pure Protein Derivative Production Process
 Figure 86. Regional Tuberculin Pure Protein Derivative Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Tuberculin Market Research Report 2025
Purified Protein Derivative Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global BCG Vaccine for Tuberculosis TB Market Research Report 2025
Global Bacille Calmette Guerin Vaccine Market Research Report 2024
Global TB Disease Vaccine Market Research Report 2025
BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global BCG and Tuberculosis Vaccine Market Research Report 2025
VPM1002 Tuberculosis BCG Based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tuberculosis Vaccination Market Research Report 2025
Global Bacillus Calmette Guerin Vaccine Market Research Report 2025
Global BCG Vaccination Market Research Report 2025
Global BCG Vaccine Market Insights Forecast to 2030
TB Vaccine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Tuberculin Syringes Market Research Report 2025
Global Plant Derived Protein Market Research Report 2024
Global Pharmaceuticals Plant Protein Market Research Report 2024
Global Tuberculin Syringe Market Insights Forecast to 2030
Global Purified Human Proteins Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Specific Protein Testing Market Research Report 2024
Global TB Vaccines Market Insights Forecast to 2030

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions